Soy Isoflavones
Soy isoflavones are a group of plant-based compounds — mainly genistein, daidzein, and glycitein — concentrated in soybeans and soy foods. They belong to
Home
What is it? Soy isoflavones are naturally occurring compounds found in soybeans and other soy products. They are classified as phytoestrogens, plant-derived compounds with estrogenic activity, and are commonly used as dietary supplements to manage hormonal imbalances and various health conditions. How does it work for medicinal purposes? Soy isoflavones mimic estrogen in the body, binding to estrogen receptors and exerting weak estrogenic effects. This can help balance hormone levels, reduce menopausal symptoms, support bone health, and provide cardiovascular and anti-cancer benefits. What are the active ingredients that are important for its medicinal properties? The primary active ingredients in soy isoflavones include: Genistein : A potent phytoestrogen with antioxidant and anti-inflammatory properties. Daidzein : Another phytoestrogen that is converted in the gut to equol, which has significant estrogenic activity. Glycitein : A less common isoflavone with mild estrogenic effects. What forms does it come in? Capsules Tablets Softgels Powders Soy protein products (e.g., soy milk, tofu) What if I have an imbalance or deficiency? There is no specific deficiency associated with soy isoflavones themselves. However, low dietary intake of phytoestrogens may affect hormonal balance, particularly during menopause, leading to symptoms that soy isoflavones can help alleviate. When was it first used for medicinal purposes? Soy has been used in traditional Asian diets for thousands of years, but the medicinal properties of soy isoflavones gained scientific attention in the mid-20th century, particularly for their role in managing menopausal symptoms and promoting bone health.
Helps
What does Soy Isoflavones help with? Soy isoflavones are plant compounds found in soybeans. Soy has been a food and a medicine in China, Japan and Korea for more than 3,000 years . Pills and extracts are a much newer idea, from the 20th century. Hot flashes and night sweats during menopause Strong evidence — the largest body of randomised human trials on file for this remedy. This is the most studied use by far. In human trials, women who took isoflavones for 8 to 12 weeks reported fewer hot flashes, and milder ones. In laboratory work, isoflavones acted weakly on estrogen receptors in the brain's heat control center. Evidence grade A · Traditional tier T0 High cholesterol Good evidence — good human trials, with a small effect size. Human studies found small drops in LDL, the "bad" cholesterol. Some studies also found mild gains in HDL, the "good" kind, mostly in women past menopause. Whole soy foods did slightly better than supplements alone. Evidence grade B · Traditional tier T0 Bone loss after menopause Good evidence — human studies running 6 to 12 months, showing modest change. Studies lasting 6 to 12 months found small gains in bone mineral density. The change showed up most in the spine. In lab work, isoflavones bind to estrogen receptors in bone tissue. Evidence grade B · Traditional tier T0 Vaginal dryness and other menopause discomfort Early evidence — small human studies of oral pills and soy creams. Some women in these studies reported less dryness and more comfort. Both pills taken by mouth and soy-based creams were tried. In lab work, isoflavones act weakly on estrogen receptors in vaginal tissue. Evidence grade C · Traditional tier T0 Blood sugar and how well your body responds to insulin Early evidence — small human studies with modest results. Two isoflavones, genistein and daidzein, have been studied here. Human results were modest, and worked best alongside a balanced diet. No large trial on file settles this use. Evidence grade C · Traditional tier T0 Heart and blood vessel health in women Early evidence — human studies that measured markers, not heart attacks. Studies measured how flexible blood vessels were, plus signs of swelling in artery walls. Both looked better in women past menopause. These are lab markers, not real-world heart events. Evidence grade C · Traditional tier T0 Lower breast cancer risk after menopause Early evidence — large population studies plus some clinical data, not randomised trials. Women who ate soy foods often, especially all their lives, had lower breast cancer rates. This is a link seen in groups of people, not proof for any one person. The data on supplements is much less clear than the data on soy foods. Evidence grade C · Traditional tier T0 Memory and mental clarity during the menopause change Early evidence — early human studies, still developing and not fully consistent. Some studies pointed to better memory and clearer thinking. Results were steadier in women early in menopause. In women long past it, results were weaker. Evidence grade C · Traditional tier T0 Prostate health in men Evidence doesn't support this — observational studies only, with no randomised trial on file. Men with higher isoflavone intake had lower rates of prostate growth and prostate cancer in these studies. That is a pattern across groups, not a tested effect. It is well established that prostate tissue carries estrogen receptors, but no trial on file has tested this use. Evidence grade D · Traditional tier T0 What Soy Isoflavones has not been shown to do Soy supplements have not been shown to lower breast cancer risk; the link on file comes from soy foods eaten over many years. No study on file tested whether isoflavones prevent broken bones, only whether bone density shifted. No study on file shows fewer heart attacks or strokes; the heart research measured blood vessel and artery markers. For memory, results were weaker in women long past menopause, so this use is not suppo
4.8
